Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.

Yemisci M, Ay H, Kocaefe C, Qui J, Topalkara K, Ozgüç M, Kirazli S, Ozcebe O, Moskowitz MA, Dalkara T.

Cerebrovasc Dis. 2008;26(2):190-8. doi: 10.1159/000145327. Epub 2008 Jul 15.

PMID:
18628618
2.

The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR.

Shimasaki Y, Saito Y, Yoshimura M, Kamitani S, Miyamoto Y, Masuda I, Nakayama M, Mizuno Y, Ogawa H, Yasue H, Nakao K.

Clin Appl Thromb Hemost. 2007 Jan;13(1):43-51.

PMID:
17164495
3.

Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.

Jantzen F, Könemann S, Wolff B, Barth S, Staudt A, Kroemer HK, Dahm JB, Felix SB, Landsberger M.

J Physiol Pharmacol. 2007 Sep;58(3):503-14.

4.

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.

Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M.

Brain Res. 2002 Jun 28;942(1-2):23-30.

PMID:
12031849
5.

Statin treatment and 3' polyadenylation of eNOS mRNA.

Kosmidou I, Moore JP, Weber M, Searles CD.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2642-9. Epub 2007 Oct 4.

6.

Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene.

Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL, Loscalzo J.

Circ Res. 1999 Jun 25;84(12):1416-21.

7.

Arginase activity is increased by thrombin: a mechanism for endothelial dysfunction in arterial thrombosis.

Yang L, Lewis CM, Chandrasekharan UM, Kinney CM, Dicorleto PE, Kashyap VS.

J Am Coll Surg. 2006 Dec;203(6):817-26. Epub 2006 Oct 25.

PMID:
17116549
8.

A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.

De Miguel LS, Jiménez A, Montón M, Farré J, Del Mar Arriero M, Rodríguez-Feo JA, García-Cañete J, Rico L, Gómez J, Núñez A, Casado S, Farré AL.

Eur J Clin Invest. 2000 Sep;30(9):811-7.

PMID:
10998082
9.

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.

Yamada M, Huang Z, Dalkara T, Endres M, Laufs U, Waeber C, Huang PL, Liao JK, Moskowitz MA.

J Cereb Blood Flow Metab. 2000 Apr;20(4):709-17.

PMID:
10779015
10.

Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways.

Rashid G, Bernheim J, Green J, Benchetrit S.

Nephrol Dial Transplant. 2007 Oct;22(10):2831-7. Epub 2007 Jun 2.

PMID:
17545677
11.

Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.

Muñoz YC, Gomez GI, Moreno M, Solis CL, Valladares LE, Velarde V.

Horm Metab Res. 2012 Jul;44(8):625-31. doi: 10.1055/s-0032-1309056. Epub 2012 Apr 19.

PMID:
22517552
12.

HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats.

Yokoyama S, Ikeda H, Haramaki N, Yasukawa H, Katoh A, Imaizumi T.

J Cardiovasc Pharmacol. 2005 Apr;45(4):375-81.

PMID:
15772528
13.

Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.

Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hübschle T, Mang C, Strobel H, Suzuki T, Kleinert H, Förstermann U, Ruetten H, Li H.

J Pharmacol Exp Ther. 2008 May;325(2):370-9. doi: 10.1124/jpet.107.128009. Epub 2008 Feb 5.

14.

Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.

Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.

Circulation. 2005 Nov 29;112(22):3486-94.

15.

Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.

Jayachandran M, Mukherjee R, Steinkamp T, LaBreche P, Bracamonte MP, Okano H, Owen WG, Miller VM.

Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2355-62. Epub 2005 Jan 14.

16.

[The effects of pravastatin on platelet-derived nitric oxide system in rabbits].

Ma LP, Kang MF, Yin SM, Nie DN, Xie SF, Wu YD, Li YQ, Feng JH, Xu LZ.

Zhonghua Xue Ye Xue Za Zhi. 2005 Sep;26(9):539-42. Chinese.

PMID:
16468331
17.

Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.

de Meirelles LR, Mendes-Ribeiro AC, Santoro MM, Mendes MA, da Silva MN, Mann GE, Brunini TM.

Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1267-71.

PMID:
17973865
18.

Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase.

Patel B, Sharifi M, Milward AD, Oberprieler NG, Gibbins JM, Parkin S, Naseem KM.

J Thromb Haemost. 2006 Nov;4(11):2423-32. Epub 2006 Aug 8.

19.

Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.

Chen H, Ren JY, Xing Y, Zhang WL, Liu X, Wu P, Wang RJ, Luo Y.

Int J Cardiol. 2009 Jan 24;131(3):313-20. doi: 10.1016/j.ijcard.2007.10.044. Epub 2008 Jan 24.

PMID:
18221806
20.

Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol.

Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE.

Pharmacogenetics. 2002 Jul;12(5):407-13.

PMID:
12142730

Supplemental Content

Support Center